The fMRI hyperscanning environment.
News | Clinical Trials
Dual Brain Imaging Provides Insight Into Neural Basis of Patient-clinician Relationship

October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is ...

Time October 22, 2020
Home
Recommendations address patient selection and treatment techniques for locally advanced disease
News | Radiation Therapy
ASTRO Issues Clinical Guideline on Radiation Therapy for Rectal Cancer

October 22, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance ...

Time October 22, 2020
Home
On Oct. 21, Seema Verma, administrator of the Centers for Medicare & Medicaid Services, tweeted that CMS will delay the Radiation Oncology Model’s launch from Jan. 1 to July 1 
News | ASTRO
ASTRO Responds to CMS Announcement on Delayed Radiation Oncology Model Start Date

October 22, 2020 — In response to the Oct. 21 announcement that the Centers for Medicare and Medicaid Services (CMS) ...

Time October 22, 2020
Home
The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer
Quantib Receives FDA Clearance for First-to-Market Prostate Solution

October 21, 2020 — Quantib, a market leader in artificial intelligence solutions for radiology, today announced that it ...

Time October 21, 2020
Home
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)
News | Magnetic Resonance Imaging (MRI)
Body MRI Reinterpretations Plagued by Discrepancies and Errors

October 21, 2020 — According to an article in ARRS' American Journal of Roentgenology (AJR), secondary interpretations ...

Time October 21, 2020
Home
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT)
Patient Dies After CT Scan Mix-up

October 21, 2020 — The BBC News reported that Luke Allard of Mill Houses, King's Lynn, died at Queen Elizabeth Hospital ...

Time October 21, 2020
Home
When new installations are ordered, the DAS team at Bracco matches a specialist with the installation based on specialty, learning style and industry awareness. This approach was helpful at Beaufort Memorial Hospital in Beaufort, S.C., which just recently transitioned to the Bracco EmpowerCTA+ Injector System.
Sponsored Content | Blog | Contrast Media
BLOG: Training and Vendor Support Key to Successful Device Upgrade

Transitioning to a new device vendor can provide improvements to outdated technology and workflow. It also requires a ...

Time October 20, 2020
Home
Flowchart of patient inclusion and exclusion.
News | Coronavirus (COVID-19)
Multi-Institutional Study Looks at Brain MRI Findings in COVID-19

October 20, 2020 — A new multi-institutional study published in the journal Radiology identifies patterns in abnormal ...

Time October 20, 2020
Home
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT)
Standard CT Technology Produces Spectral Images with Deep Learning Algorithms

October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnose ...

Time October 20, 2020
Home
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence
Ezra Receives FDA Clearance For Prostate Cancer Artificial Intelligence

October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI) ...

Time October 20, 2020
Home
Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging
Volpara Solutions Becomes Volpara Health

October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed ...

Time October 19, 2020
Home
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.
News | Lung Imaging
Researchers Develop Tool to Better Predict Treatment Course for Lung Cancer

October 19, 2020 — Personalized treatment options for patients with lung cancer have come a long way in the past two ...

Time October 19, 2020
Home
Varian, a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care during the 2020 American Society for Radiation Oncology (ASTRO) taking place virtually Oct. 24-31.
News | ASTRO
Varian Highlights Advancements in Intelligent Cancer Care at ASTRO20

October 19, 2020 — Varian, a leading provider of cancer care technologies and solutions, continues to reinforce its ...

Time October 19, 2020
Home
Carestream's Eclipse Image Processing engine, which powers Carestream software such as ImageView, aims to deliver quantifiable benefits to the radiologist and patient.
News | Artificial Intelligence
Carestream Highlights Eclipse and Artificial Intelligence at RSNA 2020

October 19, 2020 — Carestream recognizes the impact of artificial intelligence in radiology applications, and ...

Time October 19, 2020
Home
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)
News | Magnetic Resonance Imaging (MRI)
Body MRI Reinterpretations Plagued by Discrepancies and Errors

October 16, 2020 — According to an article in ARRS’ American Journal of Roentgenology (AJR), secondary interpretations ...

Time October 16, 2020
Home
Mevion Medical Systems announced that it has shipped the accelerator module for the Mevion S250i Proton Therapy System to Kunshan, China. The 15-ton compact accelerator, the heart of the proton therapy system, is the smallest of its kind and will be the first in China.
News | Proton Therapy
Mevion Ships the First Compact Accelerator Module to China

October 16, 2020 — Mevion Medical Systems announced that it has shipped the accelerator module for the Mevion S250i ...

Time October 16, 2020
Home
Fujifilm Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, and Volpara Solutions, a purpose-driven software company on a mission to prevent advanced-stage breast cancer, today announced an expanded partnership to provide mammography facilities and clinicians with breast imaging solutions designed to improve image quality, streamline workflow and accurately assess a patient's breast density.
News | Breast Imaging
Fujifilm Medical Systems and Volpara Solutions Expand Partnership for Breast Cancer Screenings

October 15, 2020 — Fujifilm Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical ...

Time October 15, 2020
Home
More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.
News | Women's Health
Trained Hands Can Reduce Advanced Breast Cancer Worldwide

October 15, 2020 — More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally ...

Time October 15, 2020
Home
Videos | MRI Breast
VIDEO: Use of Breast MRI Screening in Women With Dense Breasts

Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, explains how breast ...

Time October 14, 2020
Home
Videos | Coronavirus (COVID-19)
VIDEO: The Impact of COVID-19 on Breast Imaging

Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, explains how the COVID-19 ...

Time October 14, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now